Publication dates

All regions

Bladder Cancer Industry, October 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, therapeutics, more »


 
1-20 of about 8 500 reports for Bladder Cancer

Oryzon Genomics S.A. - Product Pipeline Analysis, 2014 Update

Oryzon Genomics S.A. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... S diagnostic products include gynec-dx for endometrial cancer; cxbladder for bladder cancer; and colobraf for colorectal cancer. The company produces nces and monoclonal antibodies for neurogeneration and cancer ...

Mitomics Inc. - Product Pipeline Analysis, 2014 Update

Mitomics Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Diagnostic assay - bladder cancer - product status 13diagnostic assay - bladder cancer - product description 13diagnostic assay - lung cancer - product status 14diagnostic assay - lung cancer ...

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2014 Update

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Product description 24mirview test - bladder cancer - product status 25mirview test - bladder cancer - product description 25rosetta genomics, ltd., Key employees 27rosetta genomics, ltd ...

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 12 800
  • Industry report
  • August 2014
  • by Venture Planning Group

... Leukemia 7. Lymphoma 8. Oral cancer 9. Skin cancer 10. Uterine cancer11. Ovarian cancer12. bladder cancer b. Major current and emerging cancer diagnostic tests 1 ...

Metabolon, Inc. - Product Pipeline Analysis, 2014 Update

Metabolon, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • August 2014
  • by Global Data

... Detection test - product status 13bladder cancer detection test - product description 13bladder cancer occult metastasis detection test - product status 14bladder cancer occult metastasis ...

Tengion, Inc. (Symbol:TNGN) SWOT Analysis, Strategy, Revenues and Profits

Tengion, Inc. (Symbol:TNGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... The company's neo-urinary conduit is used for bladder cancer patients, who need urinary diversion. Its neo-kidney augment is used for patients suffering from advanced chronic kidney disease. The company owned ...

Oncology Research Digest H1 2014

Oncology Research Digest H1 2014

  • $ 350
  • Industry report
  • August 2014
  • by TBRC Business Research

... Areas such as biosimilars, novel immunotherapies, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, ovarian cancer and drugs such as rituxan, avastin, herceptin, traceva ...

Bladder Cancer Partnering 2009-2014

Bladder Cancer Partnering 2009-2014

  • $ 695
  • Industry report
  • August 2014
  • by Currentpartnering

... Report contains over 25 links to online copies of actual bladder cancer deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under non muscle invasive bladder cancer ...

 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Drugs that fall under non muscle invasive bladder cancer (nmibc) (superficial bladder cancer). This report provides information on the therapeutic development based on the non muscle invasive bladder ...

About 900 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Sweden

  • Urinary Bladder Cancer in Wegener's Granulomatosis: Risks and Re...
  • September 2014
    6 pages
  • Bladder Cancer  

    Cancer  

  • Sweden  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.